Submission Details
| 510(k) Number | K993577 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 21, 1999 |
| Decision Date | December 01, 1999 |
| Days to Decision | 41 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K993577 is an FDA 510(k) clearance for the CEFOTAXIME/CLAVULANIC, 30/10UG, BBL SENSI-DISC AND CEFTAZIDIME/CLAVULANIC ACID, 30/10UG, BBL SENSI-DISC, a Susceptibility Test Discs, Antimicrobial (Class II — Special Controls, product code JTN), submitted by Becton Dickinson Microbiology Systems (Sparks, US). The FDA issued a Cleared decision on December 1, 1999, 41 days after receiving the submission on October 21, 1999. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.1620.
| 510(k) Number | K993577 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 21, 1999 |
| Decision Date | December 01, 1999 |
| Days to Decision | 41 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | JTN — Susceptibility Test Discs, Antimicrobial |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.1620 |